Pemetrexed
- Product NDC
- 0409-1062
- 11-digit product format
- 004091062
- Labeler code
- 0409
- Product ID
- 0409-1062_9b81e6b8-dfdd-499a-9cb4-d50103981b17
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pemetrexed
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Hospira, Inc.
- Application
- NDA208746
- Marketing category
- NDA
- Marketing start
- 2022-06-20
- Marketing end
- 0000-00-00
- Substance
- PEMETREXED TROMETHAMINE ANHYDROUS
- Active strength
- 25 mg/mL
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0409-1062 | PEMETREXED INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] | 4 | Legacy NDC | 20220723_8cdb5b46-c003-4bf6-95c2-c7af169b3f47.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0409-1062-01 | 00409106201 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1062-01) > 40 mL in 1 VIAL, SINGLE-DOSE | 2022-06-20 | 0000-00-00 | No | No | Current |